News for Abcam plc (ABC.L)

Quibim, a Valencia-based HealthTech company innovating the use of imaging biomarkers for precision medicine, announced today the close of its €47.9

18 December 2024

Strengths highlight Danaher Corp's robust portfolio in the life sciences and diagnostics segments.Weaknesses underscore challenges in product demand variabilit

According to Research by SNS Insider, Host Cell Protein Testing Market Growth is Driven by Rising Demand for Biologics, Biosimilars, and Advanced Drug...

Dive into the Tissue Diagnostics Market, projected to grow from USD 5.3 billion in 2023 to USD 9.42 billion by 2031, at a CAGR of 6.6%! Explore insights by...

The rising prevalence of chronic diseases, increased demand for biologics and biosimilars, and advancements in recombinant protein products are key factors...

Metabolism Assays Market Driven by Increase in Prevalence of Metabolic Disorders...

Britain's talent management company Learning Technologies Group would benefit from becoming American. Will it soon receive a bid from the US?

London has fallen out of favour with high-growth businesses, but a strong IPO pipeline heading into the second half of 2024 might finally stem the decline.

Growing Popularity of Organic and Eco-Conscious Food Production Techniques Fueling Integration of Taxifolin into Modern Agricultural Practices: Fact.MR...

Spotlight on Hydroxychloroquine Intensifying Due to its Enhanced Efficacy in Treating Autoimmune Disorders....

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Epigenetics Diagnostic...

19 June 2024 HARGREAVE HALE AIM VCT PLC(the “Company”) Unaudited Interim Results The Company announces its half-year...

The Global Cystatin C Assay Market Size was valued at USD 270.6 Million in 2023 and the Worldwide Cystatin C Assay Market Size is Expected to reach USD...

The medical oxygen cylinders market is anticipated to grow in the future owing to rising cases of respiratory ailments like COVID-19, pneumonia, asthma,...

Proposed Changes to BenevolentAI's Board Composition

Increasing need for rapid test results and point of care diagnostic...

The US dominates North America's protein A resin market, driven by biopharma's focus on biosimilars & enhanced quality control systems....

The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...